Literature DB >> 2903605

Intravenous infusion of midazolam, propofol and vecuronium in a patient with severe tetanus.

R Orko1, P H Rosenberg, J J Himberg.   

Abstract

An adult patient with severe tetanus was successfully treated with alternating long-term infusions of propofol (20-80 mg/h, 8 + 3 days) and midazolam (5-15 mg/h, 29 days) for sedation, and with vecuronium infusion (6-8 mg/h, 35 days) for muscle relaxation. In addition, continuous infusion of labetalol (10-20 mg/h, 39 days) was given to control arterial blood pressure. Blood samples were taken daily for assays of propofol, midazolam and vecuronium plasma concentrations. No accumulation of propofol and vecuronium could be detected. There was an increase in liver enzyme activity at the end of the first 8-day propofol infusion. During the 4-week midazolam infusion, there were two marked plasma concentration peaks at times when the infusion rate was fairly stable. These changes coincided with pulmonary infection (C-reactive protein elevated) and ciprofloxacin treatment. The patient awoke rapidly after the last propofol infusion. He was unable to recall anything about his stay in the intensive care unit.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2903605     DOI: 10.1111/j.1399-6576.1988.tb02791.x

Source DB:  PubMed          Journal:  Acta Anaesthesiol Scand        ISSN: 0001-5172            Impact factor:   2.105


  8 in total

Review 1.  Tetanus.

Authors:  J J Farrar; L M Yen; T Cook; N Fairweather; N Binh; J Parry; C M Parry
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

Review 2.  Post-neonatal tetanus: issues in intensive care management.

Authors:  S Singhi; V Jain; C Subramanian
Journal:  Indian J Pediatr       Date:  2001-03       Impact factor: 1.967

Review 3.  Propofol: a review of its use in intensive care sedation of adults.

Authors:  Kate McKeage; Caroline M Perry
Journal:  CNS Drugs       Date:  2003       Impact factor: 5.749

4.  Tetanus.

Authors:  Sarice L. Bassin
Journal:  Curr Treat Options Neurol       Date:  2004-01       Impact factor: 3.598

Review 5.  Pharmacokinetic implications for the clinical use of propofol.

Authors:  J Kanto; E Gepts
Journal:  Clin Pharmacokinet       Date:  1989-11       Impact factor: 6.447

Review 6.  Tetanus: pathophysiology, treatment, and the possibility of using botulinum toxin against tetanus-induced rigidity and spasms.

Authors:  Bjørnar Hassel
Journal:  Toxins (Basel)       Date:  2013-01-08       Impact factor: 4.546

Review 7.  Pharmacological management of tetanus: an evidence-based review.

Authors:  Chaturaka Rodrigo; Deepika Fernando; Senaka Rajapakse
Journal:  Crit Care       Date:  2014-03-26       Impact factor: 9.097

8.  Titration of high dose sedation is effective in severe tetanus: a case report.

Authors:  Pan Chun; Huang Ying-Zi; Yang Yi; Qiu Hai-Bo
Journal:  Cases J       Date:  2009-09-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.